Mar 10 |
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript
|
Mar 7 |
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
|
Mar 6 |
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
|
Mar 5 |
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
|
Mar 4 |
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
|
Feb 28 |
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference
|
Feb 15 |
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
|
Feb 14 |
Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort
|
Jan 9 |
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
|
Jan 4 |
Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024
|